Biocon's future focus on making processes robust and GMP compliance

As the chair at the helm of Biocon changes face, there is a new zeal to increase the efforts in making the processes more robust and to make them free from excessive human interference. The company is embarking on a digital journey from the quality control and process control point of view, which according to the new Managing Director Mr. Siddhartha Mittal is the next step ahead to make sure that the company in the competitive Indian drug mark....